This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Trinseo (TSE) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Trinseo (TSE) delivered earnings and revenue surprises of -700% and 18.87%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Is First Trust RBA American Industrial Renaissance ETF (AIRR) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for AIRR
Should You Invest in the First Trust RBA American Industrial Renaissance ETF (AIRR)?
by Zacks Equity Research
Sector ETF report for AIRR
Is First Trust RBA American Industrial Renaissance ETF (AIRR) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for AIRR
Should You Invest in the First Trust RBA American Industrial Renaissance ETF (AIRR)?
by Zacks Equity Research
Sector ETF report for AIRR
Proto Labs (PRLB) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Proto Labs (PRLB) delivered earnings and revenue surprises of 36.36% and 6.44%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Myers (MYE) Lags Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Myers (MYE) delivered earnings and revenue surprises of -7.32% and 6.06%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Proto Labs (PRLB) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Proto Labs (PRLB) delivered earnings and revenue surprises of 23.81% and 4.05%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Trinseo (TSE) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trinseo (TSE) delivered earnings and revenue surprises of -6.83% and 3%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Columbus McKinnon (CMCO) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Columbus McKinnon (CMCO) delivered earnings and revenue surprises of 20% and 1.85%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Proto Labs (PRLB) Tops Q3 Earnings Estimates
by Zacks Equity Research
Proto Labs (PRLB) delivered earnings and revenue surprises of 5.26% and 2.69%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Trinseo (TSE) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Trinseo (TSE) delivered earnings and revenue surprises of -14.57% and 6.33%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
5 Top Stocks to Buy on New Analysts' Coverage
by Shrabana Mukherjee
Increased analyst coverage over the past few weeks may lead to solid price appreciation for stocks like Napco Security (NSSC), Proto Labs (PRLB), Clear Secure (YOU), AVEO and Mind Medicine (MNMD).
Down 25.4% in 4 Weeks, Here's Why Proto Labs (PRLB) Looks Ripe for a Turnaround
by Zacks Equity Research
Proto Labs (PRLB) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Analysts Initiate Coverage: 5 Stocks to Buy for Higher Returns
by Shrabana Mukherjee
Increased analyst coverage over the past few weeks may lead to solid price appreciation for stocks like Professional Holding (PFHD), Trinity (TRIN), SunOpta (STKL), Arcos Dorados (ARCO) and Proto Labs (PRLB).
Here's Why Proto Labs (PRLB) Could be Great Choice for a Bottom Fisher
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Proto Labs (PRLB), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Proto Labs (PRLB) Tops Q2 Earnings Estimates
by Zacks Equity Research
Proto Labs (PRLB) delivered earnings and revenue surprises of 21.05% and 0.46%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Proto Labs (PRLB) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Proto Labs (PRLB) delivered earnings and revenue surprises of 35.71% and 2.51%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Proto Labs (PRLB) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Proto Labs (PRLB) delivered earnings and revenue surprises of 41.38% and 5.63%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Proto Labs (PRLB) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Proto Labs (PRLB) delivered earnings and revenue surprises of -12.50% and -2.03%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Proto Labs (PRLB) Q3 Earnings Expected to Decline
by Zacks Equity Research
Proto Labs (PRLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for September 21st
by Zacks Equity Research
FRO, NTES, GPRK, RXT, and PRLB have been added to the Zacks Rank #5 (Strong Sell) List on September 21, 2021
Proto Labs (PRLB) Misses Q2 Earnings Estimates
by Zacks Equity Research
Proto Labs (PRLB) delivered earnings and revenue surprises of -15.22% and 0.90%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Proto Labs (PRLB) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Proto Labs (PRLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for May 20th
by Zacks Equity Research
AXDX, CRIS, FSTR, GO, and PRLB have been added to the Zacks Rank #5 (Strong Sell) List on May 20, 2021